These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32756862)

  • 1. Renal osteodystrophy and clinical outcomes: data from the Brazilian Registry of Bone Biopsies - REBRABO.
    Carbonara CEM; Reis LMD; Quadros KRDS; Roza NAV; Sano R; Carvalho AB; Jorgetti V; Oliveira RB
    J Bras Nefrol; 2020 Jan; 42(2):138-146. PubMed ID: 32756862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of renal osteodystrophy in Brazil: a cross-sectional study.
    Carbonara CEM; Roza NAV; Reis LM; Carvalho AB; Jorgetti V; Oliveira RB
    J Bras Nefrol; 2023; 45(2):257-261. PubMed ID: 37158484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal osteodystrophy and clinical outcomes: a prospective cohort study.
    Carbonara CEM; Barreto J; Roza NAV; Quadros KDS; Reis LMD; Carvalho AB; Sposito AC; Jorgetti V; Oliveira RB
    J Bras Nefrol; 2024; 46(2):e20230119. PubMed ID: 37947359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brazilian Registry of Bone Biopsy (REBRABO): design, data elements and methodology.
    de Oliveira RB; Barreto FC; Custódio MR; Gueiros JE; Neves CL; Karohl C; Sampaio Ede A; da Costa RM; Canziani ME; Moysés RM; de Carvalho AB; Jorgetti V
    J Bras Nefrol; 2014; 36(3):352-9. PubMed ID: 25317618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
    Hsu CY; Chen LR; Chen KH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphophonates in CKD patients with low bone mineral density.
    Liu WC; Yen JF; Lang CL; Yan MT; Lu KC
    ScientificWorldJournal; 2013; 2013():837573. PubMed ID: 24501586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphological analysis of bone dynamics and metabolic bone disease. Renal Osteodystrophy and New KDIGO CKD-MBD classification].
    Tsukamoto Y
    Clin Calcium; 2011 Apr; 21(4):593-7. PubMed ID: 21447928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the role of bone biopsy in the management of patients with CKD-MBD.
    Evenepoel P; Behets GJS; Laurent MR; D'Haese PC
    J Nephrol; 2017 Oct; 30(5):645-652. PubMed ID: 28831679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.
    Pazianas M; Miller PD
    Am J Kidney Dis; 2021 Oct; 78(4):582-589. PubMed ID: 33774081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis and adynamic bone in chronic kidney disease.
    Cannata-Andía JB; Rodriguez García M; Gómez Alonso C
    J Nephrol; 2013; 26(1):73-80. PubMed ID: 23023723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience.
    Liangos O; Kirchhoff S; Buchholz J; Ketteler M
    Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
    Amerling R; Harbord NB; Pullman J; Feinfeld DA
    Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed uremic osteodystrophy: an ill-described common bone pathology in patients with chronic kidney disease.
    Elkhouli E; Nagy E; Santos CGS; Barreto FC; Chaer J; Jorgetti V; El-Husseini A
    Osteoporos Int; 2023 Dec; 34(12):2003-2012. PubMed ID: 37658999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone histomorphometry and indicators of bone and mineral metabolism in wait-listed dialysis patients.
    Keronen S; Martola L; Finne P; Burton IS; Kauppila L; Kröger H; Larsson TE; Honkanen E
    Clin Nephrol; 2016 Mar; 85(3):127-34. PubMed ID: 26833298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bone biopsy in the management of patients with renal osteodystrophy.
    Malluche HH; Monier-Faugere MC
    J Am Soc Nephrol; 1994 Mar; 4(9):1631-42. PubMed ID: 8011971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal osteodystrophy in patients on hemodialysis for more than 10 years.
    Piraino BM; Rault R; Dominguez JH; Puschett JB
    Miner Electrolyte Metab; 1986; 12(5-6):390-6. PubMed ID: 3807834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal osteodystrophy.
    Klein KL; Maxwell MH
    Orthop Clin North Am; 1984 Oct; 15(4):687-95. PubMed ID: 6493735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of osteoporosis in patients with chronic kidney disease.
    Abdalbary M; Sobh M; Elnagar S; Elhadedy MA; Elshabrawy N; Abdelsalam M; Asadipooya K; Sabry A; Halawa A; El-Husseini A
    Osteoporos Int; 2022 Nov; 33(11):2259-2274. PubMed ID: 35748896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.